Ziccum AB
Licenses ambient drying technology for creating thermostable biopharmaceuticals.
ZICC | ST
Overview
Corporate Details
- ISIN(s):
- SE0011415595 (+3 more)
- LEI:
- 5493005TADJBZHXP0U27
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Website:
- https://ziccum.com/
Description
Ziccum AB is a pharmaceutical technology company that has developed LaminarPace®, a patented ambient drying system. This technology utilizes mass transfer, rather than heat, to convert liquid biologics into thermostable, particle-engineered powders. The process is designed to gently dry sensitive biopharmaceuticals, including next-generation vaccines such as mRNA, adenovirus vectors, and adjuvanted vaccines, without causing heat degradation. The resulting dry-powder formulations are stable at room temperature, eliminating the need for cold-chain transportation and storage, and are suitable for novel administration routes. Ziccum's business model focuses on offering licenses and technology transfers to vaccine and biopharmaceutical companies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ziccum AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ziccum AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ziccum AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-13 | Ann Gidner | Other | Buy | 14,000 | 8,381.80 SEK |
Peer Companies
